Studies have shown that tumor resistance to radiotherapy is closely related to the activation of epidermal growth factor receptor (EGFR), and the amplification of EGFR in GBM results in reduced sensitivity of GBM to radiotherapy (Eskilsson et al., 2018). Here, EGFR is linked to glioblastoma.